Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HMJ-38

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Cell death caused by quinazolinone HMJ-38 challenge in oral carcinoma CAL 27 cells: dissections of endoplasmic reticulum stress, mitochondrial dysfunction and tumor xenografts.
BACKGROUND This investigation clearly clarified the synthesized and antimitotic compound, 2-(3'-methoxyphenyl)-6-pyrrolidinyl-4… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2014
2014
Effect of DNA damage response by quinazolinone analogue HMJ-38 on human umbilical vein endothelial cells
The present study aims to explore the mechanism of quinazolinone analogue HMJ-38-induced DNA damage in endothelial cells in vitro… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling.
The current study aims to investigate the antiangiogenic responses and apoptotic death of human umbilical vein endothelial cells… Expand
2004
2004
Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
We previously reported that HMJ-38 was the most potent 2-phenyl-4-quinozolinone derivative in inhibiting tubulin polymerization… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
1993
1993
2-(3''-Methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone (HMJ-38) 對HL-60血癌細胞及; Studies on the Anticancer Mechanisms of 2-(3''-Methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone (HMJ-38) in HL-60 cells and in…
 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE